Skip to content
S4842Senate2023-2024 Session

End Preapproval for Addiction Treatment

Official title

“Provides that coverage for outpatient diagnosis and treatment of substance use disorder shall not be subject to preauthorization”

Sponsor Jake AshbySD-43Affects Finance
Status
In Senate Committee
Insurance
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill prohibits insurance companies from requiring preauthorization for outpatient diagnosis and treatment of substance use disorder.

Why it matters

  1. Removes barriers to timely care. By prohibiting preauthorization, the bill ensures that people seeking outpatient diagnosis and treatment for substance use disorder can access care immediately, rather than waiting for insurance approval that can delay or disrupt treatment during critical moments.

  2. Supports medical decision-making. This change shifts more control over treatment decisions to patients and their healthcare providers, rather than insurance companies, potentially leading to more individualized and clinically appropriate care.

  3. Reduces administrative burdens. Eliminating preauthorization reduces paperwork and administrative hurdles for both providers and patients, making it easier for individuals to begin or continue substance use disorder treatment without bureaucratic obstacles.

  4. Addresses parity in coverage. The bill reinforces that substance use disorder benefits cannot be more restrictive than those for other medical conditions, helping to advance mental health and addiction treatment parity and reduce discrimination in insurance practices.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

End Preapproval for Addiction Treatment

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Jake Ashby

Senator · Senate District 43

No co-sponsors yet.

History

  1. Referred to insurance
  2. Referred to insurance

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

4842

2023-2024 Regular Sessions

IN SENATE

February 15, 2023

Introduced by Sen. ASHBY -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance

AN ACT to amend the insurance law, in relation to providing that coverage for outpatient diagnosis and treatment of substance use disorder shall not be subject to preauthorization

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subparagraph (A) of paragraph 31 of subsection (i) of section 3216 of the insurance law, as amended by section 6 of subpart A of part BB of chapter 57 of the laws of 2019, is amended to read as follows:

(A) Every policy that provides medical, major medical or similar comprehensive-type coverage shall provide outpatient coverage for the diagnosis and treatment of substance use disorder, including detoxification and rehabilitation services. Such coverage shall not be subject to preauthorization and shall not apply financial requirements or treatment limitations to outpatient substance use disorder benefits that are more restrictive than the predominant financial requirements and treatment limitations applied to substantially all medical and surgical benefits covered by the policy.

§ 2. Subparagraph (A) of paragraph 7 of subsection (1) of section 3221 of the insurance law, as amended by section 16 of subpart A of part BB of chapter 57 of the laws of 2019, is amended to read as follows:

(A) Every policy that provides medical, major medical or similar comprehensive-type coverage shall provide outpatient coverage for the diagnosis and treatment of substance use disorder, including detoxification and rehabilitation services. Such coverage shall not be subject to preauthorization and shall not apply financial requirements or treatment limitations to outpatient substance use disorder benefits that are more restrictive than the predominant financial requirements and treatment

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD09227-01-3

limitations applied to substantially all medical and surgical benefits covered by the policy.

§ 3. Paragraph 1 of subsection (l) of section 4303 of the insurance law, as amended by section 27 of subpart A of part BB of chapter 57 of the laws of 2019, is amended to read as follows:

(1) Every contract that provides medical, major medical or similar comprehensive-type coverage shall provide outpatient coverage for the diagnosis and treatment of substance use disorder, including detoxification and rehabilitation services. Such coverage shall not be subject to preauthorization and shall not apply financial requirements or treatment limitations to outpatient substance use disorder benefits that are more restrictive than the predominant financial requirements and treatment limitations applied to substantially all medical and surgical benefits covered by the contract.

§ 4. This act shall take effect immediately, and shall apply to polices and contracts issued, renewed, modified, altered or amended on or after such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the insurance law, in relation to providing that cover- age for outpatient diagnosis and treatment of substance use disorder shall not be subject to preauthorization

Purpose

To make it easier for people to access treatment for substance use by removing the need for preauthorization of insurance.

Summary of provisions

Sections 1,2 and 3 of this bill amend insurance law, by stating that coverage for outpatient diagnosis and treatment of substance use disor- der provided by policies providing medical coverage shall not be subject to preauthorization.

Section 4 provides the effective date.

Justification

The aim of this bill is to work towards removing one of the many exist- ing barriers to substance use treatment: the need to seek prior authori- zation from their insurance before starting treatment. This would allow people to avoid any delays in the initiation of care. Getting people into treatment is a critical moment, and every minute saves patients from continued substance use, medical complications, overdose and death.

In 2016, the Senate's Task Force on Heroin and Opioid Addiction released a report with recommendations. Many of the recommendations were adopted that year, including provisions which made it easier of people to access treatment, by among other things, requiring health plan coverage, with- out preauthorization, of in-network inpatient treatment by OASAS certi- fied providers. The state also adopted legislation to prohibit for the first 14 days of treatment-concurrent utilization review.

This legislation builds upon those reforms, by prohibiting preauthori- zation for outpatient treatment of substance use disorder, making it easier to access treatment and maintain sobriety.

Legislative history

2021-22 - S.1915: Referred to Insurance

2019-20 - S.333: Referred to Insurance

2018 - S.8046: Referred to Insurance

Fiscal implications

To be determined, provided savings should accrue as those ready for recovery can access outpatient care quicker and avoid the costly conse- quences of returning to abusing substances.

Effective date

This act shall take effect immediately, and shall apply to policies and contracts issued, renewed, modified, altered or amended on or after such date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.